Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Welt

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1990
Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33S Welt, C R Divgi, F X Real, et al.
International Journal of Cancer|July 18, 2000
Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenograftsP M Deckert, A Jungbluth, N Montalto, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1987
Monoclonal antibody to an intracellular antigen images human melanoma transplants in nu/nu miceS Welt, M J Mattes, R Grando, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancerS Welt, C R Divgi, N Kemeny, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 1994
Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinantsK Kitamura, E Stockert, P Garin-Chesa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblastsS Welt, C R Divgi, A M Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancerS Welt, A M Scott, C R Divgi, et al.
British Journal of Clinical Pharmacology|March 22, 2001
Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patientsP Tanswell, P Garin-Chesa, W J Rettig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250E Oosterwijk, N H Bander, C R Divgi, et al.
British Journal of Cancer|August 1, 1996
Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM)P Antoniw, A P Farnsworth, A Turner, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1990
Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33S Welt, C R Divgi, F X Real, et al.
International Journal of Cancer|July 18, 2000
Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenograftsP M Deckert, A Jungbluth, N Montalto, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1987
Monoclonal antibody to an intracellular antigen images human melanoma transplants in nu/nu miceS Welt, M J Mattes, R Grando, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancerS Welt, C R Divgi, N Kemeny, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 1994
Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinantsK Kitamura, E Stockert, P Garin-Chesa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblastsS Welt, C R Divgi, A M Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancerS Welt, A M Scott, C R Divgi, et al.
British Journal of Clinical Pharmacology|March 22, 2001
Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patientsP Tanswell, P Garin-Chesa, W J Rettig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250E Oosterwijk, N H Bander, C R Divgi, et al.
British Journal of Cancer|August 1, 1996
Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM)P Antoniw, A P Farnsworth, A Turner, et al.
Pageof 7